Payment overview · 2025
General Payments
$27.32
1 reported records · 1 companies
Healthcare provider profile · identity verified
Isabel Rico, M.D.
Allopathic & Osteopathic Physicians|General Practice · MIAMI, FL · NPI 1245333145
Verified facts
What the public records show
CMS Open Payments records show Isabel Rico, M.D. received $27.32 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $27.32 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $27.32 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $27.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 507 | 70 |
| Atorvastatin Calcium | Atorvastatin Calcium | 479 | 71 |
| Pantoprazole Sodium | Pantoprazole Sodium | 475 | 79 |
| Losartan Potassium | Losartan Potassium | 442 | 65 |
| Amlodipine Besylate | Amlodipine Besylate | 394 | 57 |
| Metformin Hcl | Metformin Hcl | 386 | 52 |
| Omeprazole | Omeprazole | 359 | 62 |
| Gabapentin | Gabapentin | 294 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 275 | 48 |
| Ssd | Silver Sulfadiazine | 271 | 50 |
| Montelukast Sodium | Montelukast Sodium | 268 | 45 |
| Lisinopril | Lisinopril | 266 | 41 |
| Simvastatin | Simvastatin | 262 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 246 | 33 |
| Eliquis | Apixaban | 226 | 34 |
| Furosemide | Furosemide | 225 | 39 |
| Famotidine | Famotidine | 213 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 205 | 31 |
| Donepezil Hcl | Donepezil Hcl | 171 | 34 |
| Mirtazapine | Mirtazapine | 168 | 35 |
| Trazodone Hcl | Trazodone Hcl | 165 | 35 |
| Diclofenac Sodium | Diclofenac Sodium | 161 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 160 | 27 |
| Silver Sulfadiazine | Silver Sulfadiazine | 159 | 35 |
| Lactulose | Lactulose | 158 | 33 |
| Carvedilol | Carvedilol | 157 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 155 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 150 | 29 |
| Ammonium Lactate | Ammonium Lactate | 146 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 143 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 129 | 24 |
| Xarelto | Rivaroxaban | 119 | 16 |
| Ozempic | Semaglutide | 115 | 14 |
| Sucralfate | Sucralfate | 111 | 13 |
| Mupirocin | Mupirocin | 105 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 104 | 20 |
| Memantine Hcl | Memantine Hcl | 102 | 22 |
| Divalproex Sodium | Divalproex Sodium | 90 | 11 |
| Atenolol | Atenolol | 87 | 13 |
| Glipizide | Glipizide | 85 | 12 |
| Azithromycin | Azithromycin | 81 | 60 |
| Nystatin | Nystatin | 81 | 19 |
| Levofloxacin | Levofloxacin | 80 | 63 |
| Megestrol Acetate | Megestrol Acetate | 78 | 19 |
| Alendronate Sodium | Alendronate Sodium | 75 | 11 |
| Glimepiride | Glimepiride | 70 | suppressed |
| Levetiracetam | Levetiracetam | 67 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 66 | 14 |
| Ibuprofen | Ibuprofen | 66 | 20 |
| Myrbetriq | Mirabegron | 65 | 11 |
| Latanoprost | Latanoprost | 63 | 12 |
| Bumetanide | Bumetanide | 62 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 62 | suppressed |
| Clotrimazole | Clotrimazole | 62 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 61 | suppressed |
| Finasteride | Finasteride | 61 | suppressed |
| Allopurinol | Allopurinol | 60 | 13 |
| Chlorthalidone | Chlorthalidone | 60 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 60 | 13 |
| Clonidine Hcl | Clonidine Hcl | 58 | suppressed |
| Ketoconazole | Ketoconazole | 58 | suppressed |
| Nystop | Nystatin | 58 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 56 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 55 | suppressed |
| Potassium Chloride | Potassium Chloride | 54 | 14 |
| Sertraline Hcl | Sertraline Hcl | 52 | suppressed |
| Jardiance | Empagliflozin | 51 | suppressed |
| Folic Acid | Folic Acid | 50 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 50 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 49 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 48 | suppressed |
| Entresto | Sacubitril/Valsartan | 47 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 45 | suppressed |
| Irbesartan | Irbesartan | 45 | suppressed |
| Linzess | Linaclotide | 45 | suppressed |
| Digoxin | Digoxin | 44 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 43 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 43 | suppressed |
| Vascepa | Icosapent Ethyl | 43 | suppressed |
| Lorazepam | Lorazepam | 42 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 40 | suppressed |
| Spironolactone | Spironolactone | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | 11 |
| Santyl | Collagenase Clostridium Hist. | 34 | 17 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 33 | suppressed |
| Temazepam | Temazepam | 33 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 33 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Ezetimibe | Ezetimibe | 32 | suppressed |
| Meloxicam | Meloxicam | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Clonazepam | Clonazepam | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Metolazone | Metolazone | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Valsartan | Valsartan | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 25 | suppressed |
| Prednisone | Prednisone | 25 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 24 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Levemir | Insulin Detemir | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 20 |
| Constulose | Lactulose | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 20 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 20 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | suppressed |
| Alprazolam | Alprazolam | 18 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Restasis | Cyclosporine | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Pentoxifylline | Pentoxifylline | 15 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 14 | 13 |
| Celecoxib | Celecoxib | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Proctozone-Hc | Hydrocortisone | 14 | suppressed |
| Timolol Maleate | Timolol Maleate | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Cefdinir | Cefdinir | 13 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 11 |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Tobramycin | Tobramycin | 12 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $27.32 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error